Back to Search
Start Over
CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.
- Source :
-
Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2010 Jun; Vol. 33 (5), pp. 510-22. - Publication Year :
- 2010
-
Abstract
- The requirement for CD4 T cells in priming and maintaining cytotoxic T-lymphocyte responses presents a long-standing paradox in cellular immunology. In this study, we used sequential coadministration of a DNA vaccine encoding an invariant (Ii) chain in which the class II-associated Ii-peptide region is replaced with CD4 T-helper epitope, PADRE [Pan human leukocyte antigen-DR reactive epitope (Ii-PADRE)] or Bcl-xL with a DNA vaccine encoding Sig/E7/LAMP-1 to verify the role of CD4 T cells for the generation of effectors and memory E7-specific CD8 T-cell immune responses. Sequential vaccination, with Ii-PADRE+Sig/E7/LAMP-1 priming followed by Bcl-xL+Sig/E7/LAMP-1 boosting led to generation of E7-specific CD8 T cells, and was nearly equivalent in effect to coadministration with Ii-PADRE+Sig/E7/LAMP-1 or Bcl-xL+Sig/E7/LAMP-1 at both prime and boost. The mice vaccinated with the Ii-PADRE+Sig/E7/LAMP-1 prime-Bcl-xL+Sig/E7/LAMP-1 boost regimen exhibited better long-term E7-specific immune responses and tumor prevention effects in vivo than the mice vaccinated with the reverse sequential coadministration. After CD4 T-cell depletion, mice primed with Ii-PADRE+Sig/E7/LAMP-1 generated low numbers of E7-specific CD8 T cells and suppressed long-term memory CD8 T-cell response regardless of the sequence or combination of DNA vaccines administered. Mice primed with Bcl-xL+Sig/E7/LAMP-1 only suppressed long-term memory CD8 T-cell response after depletion of CD4 T cells before priming. Our findings suggest that activated CD4 T cells at prime phase are important to generate the antigen-specific CD8 T-cell immune responses and CD4 T cells, which are naive or activated, play a role to maintain the long-term memory responses.
- Subjects :
- Animals
Antigens, Differentiation, B-Lymphocyte genetics
Antigens, Differentiation, B-Lymphocyte immunology
Antigens, Differentiation, B-Lymphocyte metabolism
CD4-Positive T-Lymphocytes immunology
CD4-Positive T-Lymphocytes pathology
CD8-Positive T-Lymphocytes immunology
CD8-Positive T-Lymphocytes pathology
Cell Communication
Cytotoxicity, Immunologic drug effects
Histocompatibility Antigens Class II genetics
Histocompatibility Antigens Class II immunology
Histocompatibility Antigens Class II metabolism
Immunization, Secondary
Immunologic Memory drug effects
Lymphocyte Activation drug effects
Lymphocyte Depletion
Malaria Vaccines genetics
Malaria Vaccines immunology
Malaria Vaccines metabolism
Mice
Mice, Inbred C57BL
Papillomavirus E7 Proteins genetics
Papillomavirus E7 Proteins immunology
Papillomavirus E7 Proteins metabolism
Protein Engineering
Recombinant Fusion Proteins genetics
Recombinant Fusion Proteins immunology
Recombinant Fusion Proteins metabolism
Th1 Cells immunology
Th1 Cells pathology
Vaccines, DNA immunology
bcl-X Protein genetics
bcl-X Protein immunology
bcl-X Protein metabolism
CD4-Positive T-Lymphocytes metabolism
CD8-Positive T-Lymphocytes metabolism
Cancer Vaccines
Th1 Cells metabolism
Vaccines, DNA administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 1537-4513
- Volume :
- 33
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of immunotherapy (Hagerstown, Md. : 1997)
- Publication Type :
- Academic Journal
- Accession number :
- 20463596
- Full Text :
- https://doi.org/10.1097/CJI.0b013e3181d75cef